BioNTech SE (BNTX) vs Centene Corp. (CNC)

A side-by-side comparison of BioNTech SE and Centene Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBNTX vs CNC

growth of $100 · dividends reinvested · last 7y
BNTX +705.0% (+34.7%/yr)CNC +51.4% (+6.1%/yr)BNTX compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $100202120232025$805$151
BNTX CNC

BNTX vs CNC: by the numbers

  • CNC is the larger company ($31.96B vs $28.42B market cap).
  • Both run net losses; CNC's is the smaller (-2.63% vs -62.98% net margin).
  • BNTX grew revenue faster over the past five years (40.61% vs 10.35% CAGR).

Metrics side by side

Valuation

MetricBNTXCNC
Forward P/EN/A13.66
P/S ratio9.250.17
P/B ratio1.411.43
FCF yield2.16%27.86%

Profitability

MetricBNTXCNC
Gross margin70.98%16.13%
Operating margin-22.63%-2.82%
Net margin-62.98%-2.63%
ROE-9.62%-22.60%
ROIC-10.37%-12.90%

Growth (annualized)

MetricBNTXCNC
Revenue CAGR (5Y)40.61%10.35%
FCF CAGR (5Y)N/A-1.39%
Total return CAGR (5Y)-19.15%0.25%

Frequently asked

Which has grown faster, BNTX or CNC?
Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus CNC at 10.35%.
How have BNTX and CNC total returns compared?
Over the past 5 years, BNTX delivered -19.15% and CNC delivered 6.33% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.